Ariel is a capital markets partner in the London office and specialises in equity capital markets transactions (including IPOs and secondary offerings), corporate governance matters and general public company representation. She has a particular focus on the Tech and Life Sciences sectors.

She trained at Freshfields Bruckhaus Deringer and subsequently spent over 10 years in the London offices of Davis Polk & Wardwell and Latham & Watkins, including spending time on secondment at global investment banks Goldman Sachs, Jefferies and Citi.

Ariel is a member of the firm’s ESG & Impact Group and Public Company Advisory Practice and regularly advises listed and later stage private companies on their ESG obligations. She is also a member of Goodwin’s Women’s Health & Wellness group and serves on the firm’s Steering Committee focused on the ESG implications of the US Supreme Court Dobbs decision for the firm and its clients.